by Elana Gotkine Venous thromboembolism (VTE) risk varies across hormonal contraceptives, according to a research letter published online Feb. 10 in the Journal of the American Medical Association. Harman Gailan Hassan Yonis, M.D., from Aalborg University Hospital in Denmark, and colleagues examined VTE risk across contemporary hormonal contraceptives using Danish national registers including all females aged 15 to 49 years....
Tag: <span>hormonal contraceptives</span>
Post
Do hormonal contraceptives impact glaucoma risk?
WILEY Women who currently use hormonal contraceptives face more than a 2-fold higher risk of developing glaucoma, according to an analysis of electronic medical records for women aged 15-45 years from 2008 to 2018. The British Journal of Clinical Pharmacology analysis included 2,366 women who developed glaucoma and 9,464 controls. Although current users of hormonal contraceptives may have a...